NCT07487779

Brief Summary

This study aims to find out if a specific exercise program helps patients with Rheumatoid Arthritis (RA). RA is a chronic autoimmune disease that causes pain, weakness, and reduced function in the joints and muscles. While medication is common, exercise is also important for management. The study will test a program called "Progressive Resistance Training." About 118 adult patients with RA at AL-Najaf Teaching Hospital will participate. They will be divided into two groups. One group will perform specific resistance exercises for six weeks, while the other group will continue their usual care without this specific training. The researchers will measure muscle strength, cardiovascular function, and energy levels before and after the six-week program. The goal is to determine if this exercise improves muscle strength and helps patients perform daily activities more efficiently. The study hopes to show that resistance training is a safe and effective way to improve quality of life for people with RA.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
118

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Apr 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Apr 2026Jul 2026

First Submitted

Initial submission to the registry

March 17, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 23, 2026

Completed
9 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

April 1, 2026

Status Verified

March 1, 2026

Enrollment Period

1 month

First QC Date

March 17, 2026

Last Update Submit

March 26, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Muscle Strength from Baseline to 6 Weeks

    Muscle strength will be measured using manual muscle testing or dynamometer for upper and lower extremities

    Baseline and 6 weeks post-intervention

Study Arms (2)

Progressive Resistance Training Group

ACTIVE COMPARATOR

Participants in this group will receive a supervised Progressive Resistance Training (PRT) program for 6 weeks. The intervention includes: * Resistance exercises 3 times per week * Sessions lasting 45-60 minutes each * Exercises targeting major muscle groups of upper and lower extremities * Use of resistance bands, light weights, and body weight exercises * Progressive intensity starting at 40-50% and increasing to 60-70% of maximum capacity * 8-12 repetitions per set, 2-3 sets per exercise * Supervised by trained physical therapist at AL-Najaf Teaching Hospital * Regular monitoring of pain, fatigue, and disease activity The program is designed to improve muscle strength in patients with Rheumatoid Arthritis while maintaining safety and avoiding disease exacerbation.

Other: Progressive Resistance Training

Control Group - Standard Care

NO INTERVENTION

Interventions

Progressive Resistance Training (PRT) program for patients with Rheumatoid Arthritis. The intervention consists of supervised resistance exercises targeting major muscle groups of upper and lower extremities. Program Details: * Duration: 6 weeks * Frequency: 3 sessions per week * Session duration: 45-60 minutes * Setting: AL-Najaf Teaching Hospital Exercise Components: * Warm-up exercises (10 minutes) * Resistance training using resistance bands, light weights, and body weight exercises (30-40 minutes) * Cool-down and stretching (10 minutes) Progression Method: * Intensity starts at 40-50% of maximum capacity * Gradually increases to 60-70% over 6 weeks * Repetitions: 8-12 per set * Sets: 2-3 sets per exercise * Exercises adjusted based on individual tolerance and disease activity Supervision: Trained physical therapist/nurse supervision with regular monitoring of pain levels, fatigue, and joint swelling. The program is designed specifically for RA patients with mild to moderate

Progressive Resistance Training Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with Rheumatoid Arthritis according to American College of Rheumatology criteria
  • Age 18-65 years
  • Both genders eligible
  • Disease duration of at least 6 months
  • Stable medication regimen for at least 3 months before study
  • Mild to moderate disease activity
  • Able to walk independently with or without assistive devices
  • Willing and able to provide informed consent
  • Agree to participate in the exercise program for 6 weeks
  • Attending AL-Najaf Teaching Hospital for RA management

You may not qualify if:

  • Severe cardiovascular disease (unstable angina, recent MI, severe heart failure)
  • Other inflammatory arthritis (psoriatic arthritis, ankylosing spondylitis, lupus)-
  • Recent joint surgery or fracture within the past 6 months
  • Severe osteoporosis with fracture risk
  • Pregnancy
  • Severe cognitive impairment preventing participation
  • Uncontrolled hypertension (BP \>180/110 mmHg)
  • Active infection or fever at baseline
  • Severe joint damage preventing exercise participation
  • Participation in another exercise program during the study period
  • Neuromuscular disorders affecting muscle function

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Arthritis, Rheumatoid

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Nursing

Study Record Dates

First Submitted

March 17, 2026

First Posted

March 23, 2026

Study Start

April 1, 2026

Primary Completion

May 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

April 1, 2026

Record last verified: 2026-03